2.005
price down icon4.29%   -0.095
 
loading

Pulmonx Corp Azioni (LUNG) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
5.86%
23.86
22.54 20.78 18.85
Cost Of Revenue
7.41%
6.655
6.196 5.476 4.776
Gross Profit
5.27%
17.20
16.34 15.31 14.08
Operating Expenses
3.57%
32.01
30.91 30.93 28.61
Benefits Costs and Expenses
5.44%
38.85
36.85 36.02 32.42
Costs And Expenses
5.44%
38.85
36.85 36.02 32.42
Operating Income/Loss
1.65%
-14.80
-14.56 -15.62 -14.54
Income/Loss From Continuing Operations Before Tax
4.77%
-15.00
-14.31 -15.24 -13.56
Income Tax Expense/Benefit
31.11%
0.177
0.135 0.084 0.186
Income/Loss From Continuing Operations After Tax
5.02%
-15.17
-14.45 -15.33 -13.75
Net Income/Loss
5.02%
-15.17
-14.45 -15.33 -13.75
Preferred Stock Dividends And Other Adjustments
-
- - -
Attributable To Noncontrolling Interest
-
- - -
Basic Average Shares
1.19%
40.43
39.95 38.94 38.64
Diluted Average Shares
1.19%
40.43
39.95 38.94 38.64
Basic Earnings Per Share
5.56%
-0.38
-0.36 -0.39 -0.36
Diluted Earnings Per Share
5.56%
-0.38
-0.36 -0.39 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - -
$290.94
price down icon 0.54%
medical_devices STE
$258.82
price down icon 0.47%
$66.89
price down icon 2.73%
medical_devices PHG
$29.57
price up icon 0.51%
$87.82
price up icon 0.21%
medical_devices EW
$85.03
price up icon 0.50%
Capitalizzazione:     |  Volume (24 ore):